PTEN hamartoma tumor syndromes

بواسطة Blumenthal, Gideon M, Dennis, Phillip A
الحاوية / القاعدة Eur J Hum Genet (2008)

PTEN loss in the continuum of common cancers, rare syndromes and mouse models

بواسطة Hollander, M. Christine, Blumenthal, Gideon M., Dennis, Phillip A.
الحاوية / القاعدة Nat Rev Cancer (2011)

Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non–Small Cell Lung Cancer

بواسطة Kazandjian, Dickran, Gong, Yutao, Keegan, Patricia, Pazdur, Richard, Blumenthal, Gideon M.
الحاوية / القاعدة JAMA Oncol (2019)

Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations

بواسطة LoPiccolo, Jaclyn, Blumenthal, Gideon M., Bernstein, Wendy B., Dennis, Phillip A.
منشور في 2007

The FDA Oncology Center of Excellence and precision medicine

بواسطة Goldberg, Kirsten B, Blumenthal, Gideon M, McKee, Amy E, Pazdur, Richard
الحاوية / القاعدة Exp Biol Med (Maywood) (2017)

FDA Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic Non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1

بواسطة Sul, Joohee, Blumenthal, Gideon M., Jiang, Xiaoping, He, Kun, Keegan, Patricia, Pazdur, Richard
الحاوية / القاعدة Oncologist (2016)

Management of Reproductive Health in Cowden Syndrome Complicated by Endometrial Polyps and Breast Cancer

بواسطة Kalin, Asli, Merideth, Melissa A., Regier, Debra S., Blumenthal, Gideon M., Dennis, Phillip A., Stratton, Pamela
منشور في 2013

Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer

بواسطة Kazandjian, Dickran, Blumenthal, Gideon M., Luo, Lola, He, Kun, Fran, Ingrid, Lemery, Steven, Pazdur, Richard
الحاوية / القاعدة Oncologist (2016)

Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies

بواسطة Blumenthal, Gideon M., Kluetz, Paul G., Schneider, Julie, Goldberg, Kirsten B., McKee, Amy E., Pazdur, Richard
الحاوية / القاعدة Oncologist (2017)

Accelerating Early Access to Immunotherapies for Advanced Urothelial Carcinoma

بواسطة Ning, Yang‐Min, Maher, V. Ellen, Beaver, Julia A., Goldberg, Kirsten B., Blumenthal, Gideon M., Pazdur, Richard
الحاوية / القاعدة Oncologist (2017)

FDA Approval Summary: Sunitinib for the Treatment of Progressive Well-Differentiated Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors

بواسطة Blumenthal, Gideon M., Cortazar, Patricia, Zhang, Jenny J., Tang, Shenghui, Sridhara, Rajeshwari, Murgo, Anthony, Justice, Robert, Pazdur, Richard
منشور في 2012

FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements

بواسطة Kazandjian, Dickran, Blumenthal, Gideon M., Chen, Huan-Yu, He, Kun, Patel, Mona, Justice, Robert, Keegan, Patricia, Pazdur, Richard
منشور في 2014

An FDA Perspective on the Regulatory Implications of Complex Signatures to Predict Response to Targeted Therapies

بواسطة Beaver, Julia A., Tzou, Abraham, Blumenthal, Gideon M., McKee, Amy E., Kim, Geoffrey, Pazdur, Richard, Philip, Reena
الحاوية / القاعدة Clin Cancer Res (2016)

U.S. Food and Drug Administration Approval Summary: Erlotinib for the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 19 De...

بواسطة Khozin, Sean, Blumenthal, Gideon M., Jiang, Xiaoping, He, Kun, Boyd, Karen, Murgo, Anthony, Justice, Robert, Keegan, Patricia, Pazdur, Richard
منشور في 2014

U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based...

بواسطة Larkins, Erin, Scepura, Barbara, Blumenthal, Gideon M., Bloomquist, Erik, Tang, Shenghui, Biable, Missiratch, Kluetz, Paul, Keegan, Patricia, Pazdur, Richard
الحاوية / القاعدة Oncologist (2015)

Evaluation of Serious Postmarket Safety Signals Within 2 Years of FDA Approval for New Cancer Drugs

بواسطة Kim, Janice, Nair, Abhilasha, Keegan, Patricia, Beaver, Julia A., Kluetz, Paul G., Pazdur, Richard, Chuk, Meredith, Blumenthal, Gideon M.
الحاوية / القاعدة Oncologist (2019)

An Analysis of Recent FDA Oncology Scientific Publications

بواسطة Schneider, Julie A., Miklos, Andrew C., Onken, James, Gong, Yutao, Calcagno, Anna Maria, Blumenthal, Gideon M., Aragon, Richard, Pazdur, Richard
الحاوية / القاعدة Oncologist (2019)

A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma

بواسطة Raju, G.K., Gurumurthi, Karthik, Domike, Reuben, Kazandjian, Dickran, Landgren, Ola, Blumenthal, Gideon M., Farrell, Ann, Pazdur, Richard, Woodcock, Janet
الحاوية / القاعدة Clin Pharmacol Ther (2017)

Milestone Analyses of Immune Checkpoint Inhibitors, Targeted Therapy, and Conventional Therapy in Metastatic Non–Small Cell Lung Cancer Trials: A Meta-analysis

بواسطة Blumenthal, Gideon M., Zhang, Lijun, Zhang, Hui, Kazandjian, Dickran, Khozin, Sean, Tang, Shenghui, Goldberg, Kirsten, Sridhara, Rajeshwari, Keegan, Patricia, Pazdur, Richard
الحاوية / القاعدة JAMA Oncol (2017)

Reproducibility of pharmacogenetics findings for paclitaxel in a heterogeneous population of patients with lung cancer

بواسطة Sissung, Tristan M., Rajan, Arun, Blumenthal, Gideon M., Liewehr, David J., Steinberg, Seth M., Berman, Arlene, Giaccone, Giuseppe, Figg, William D.
الحاوية / القاعدة PLoS One (2019)